Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : The Naked Truth - Big Kahuna a Myth -- Ignore unavailable to you. Want to Upgrade?

To: yard_man who wrote (10198)	11/3/1998 2:59:00 PM
From: Cynic 2005	Read Replies (1) \| Respond to of 86076

Tip, we hung on to the losers (puts) and punted a golden one. Ouch, it hurts, man! BSX still not open for trading: Tuesday November 3, 2:06 pm Eastern Time Company Press Release SOURCE: Boston Scientific Corporation Boston Scientific Addresses Japan Business Irregularities NATICK, Mass., Nov. 3 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX - news) announced today that in connection with certain routine internal review, analysis and audit procedures, it has detected the occurrence of business irregularities in the operations of its Japanese subsidiary. The irregularities detected involve shipments of products that have been improperly recorded as sales to the subsidiary's dealer network in Japan. Based on preliminary information, the magnitude of the irregularities detected is believed to range between $40 and $50 million in improperly recorded sales for the nine months ended September 30, 1998, and, additionally, net unrealizable assets of approximately $40 million related to similar improper sales recorded in prior periods. The Company expects to report sales for 1998 in excess of $2 billion dollars worldwide and it believes that the irregularities identified are limited to the Japan operations. The Company is in the process of aggressively investigating further the irregularities identified and is attempting to determine the effect, if any, on previously issued financial statements. The Company hopes to complete its investigation within the next several weeks. Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices. The Company's products are used in a broad range of interventional medical specialties. This press release contains forward looking statements. The Company wishes to caution the reader of this press release that actual results may differ from those discussed in the forward looking statements and may be adversely affected by, among other things, findings of the ongoing investigation, the ability of the Company to implement its overall business strategy in Japan and worldwide, and other factors described in the Company's filings with the Securities and Exchange Commission.